WTI Crude


Brent Crude


Natural Gas




Heating Oil


Rotate device for more commodity prices

Breaking News:

Nigeria Announces $41 Billion Rail Upgrade

Alt Text

Can Oil Sanctions Cripple North Korea’s Army?

As tensions between the U.S.…

Alt Text

Are Oil Bulls About To Be Burned Again?

Oil markets have just seen…

Charles Kennedy

Charles Kennedy

Charles is a writer for Oilprice.com

More Info

Smart Money Backing A Marijuana Boom In 2017

cannabis plant

This little-known marijuana company is the only real entry point into the multi-billion-dollar Canadian pot market, and it’s also the first marijuana company to pay a dividend to its shareholders.

Pot stocks were already skyrocketing—in some cases beyond 1700%--in anticipation that the Canadian government would put legislation on the table to legalize marijuana for recreational use in April.

That’s already happened, and now stocks are going wild because it should all be legal by July 1st, 2018. This is the making of a multi-billion-dollar market overnight.

And this company could be the way in ...

Meet Invictus MD (TSX:IMH.V; OTC:IVITF)—a small-cap that has redefined savvy in this sector and will be walking with the jolly green giants by this time next year—when high valuations will slam doors shut and only billionaires will emerge.

The Fast-Track to Profits—The Lucrative Pot Pre-Approval

In what will prove to be the biggest multi-decade opportunity for investors, Invictus has already won pre-approval by the Canadian health authority to produce 15 strains of marijuana.

And this is only one of many firsts for this small-cap.

Right out of the gate, Invictus MD, owner of two of only 50 licenses, has demonstrated that it will lead the way. And it’s cashed up and already generating dividends—a feat unheard of in the pot industry.

That’s why it’s called ‘Canada’s Cannabis Company’—it’s already cemented market share for medical marijuana use, and now it’s one of the first in and ready to fill the supply gap for a massive recreational push.

It’s also the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and – most lucratively of all—recreation, the sky is the limit here.

Supply Deficit Looming—This is Bigger Than Beer

We’re now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.

The industry is scrambling to add greater capacity once these legal barriers are tossed aside.

Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That’s more than the combined sales of beer, wine and spirits.

We’re going to be playing some serious catch-up, which is a producer’s dream.

• Legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year in Canada, according to Canaccord Genuity analysts. (And that’s just for recreational use.)

• Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.

• Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021—up from nearly $7 billion last year. That’s an annual growth rate of 26 percent, and it’s in line with Deloitte’s own estimations.

• In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.

That’s what happens when you end ‘prohibition’ for a market that is already huge—it’s just hiding under the table. But this will blow away the billion-dollar industry that was reborn the moment alcohol prohibition ended on December 5, 1933.

Investors get it. That’s why shares of medical marijuana producers more than tripled last year—just at the anticipation, and now that it is set to become legal, there is no telling what could happen.

• AXIM Biotechnologies (NASDAQOTH:AXIM): exploded 1,720 percent
• Corbus Pharmaceuticals (NASDAQ:CRBP) was up 431 percent
• Aphria (NASDAQOTH:APHQF) grew 381 percent
• Aurora Cannabis (NASDAQOTH:ACBFF) was up 299 percent
• Canopy Growth Corp. (NASDAQOTH:TWMJF) up 259 percent
• Medical Marijuana (NASDAQOTH:MJNA) up 254 percent
• GW Pharmaceuticals (NASDAQ:GWPH) was up 64 percent

In early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.

On 23 June, Invictus was included in the ETF.

Way Ahead of the Game, with a Massive Pot Pipeline

Invictus MD (TSX:IMH.V; OTC:IVITF) has multiple projects in its Canadian investment pipeline—all of them bolstered by some extremely savvy acquisitions. And they’re not afraid of picks and shovels; they’re all about hard work, if it’s smart.

Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the ‘picks and shovels’ of the cannabis space. Invictus MD has made one smart move after another, and it’s always the ‘pick and shovel’ guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it less than a year before. That’s how they managed their first shareholder dividend.

They’ve been targeting small- and mid-size companies with significant growth potential and direct their strategies towards profitability. And this business savvy gives them everything they need to produce cheaply and to corner this market—but still maintain a valuation far below their peers. That why this is a very real entry point into this market for potential outsized gains.

The pipeline is impressive:

• 33% ownership in AB Laboratories Inc., which received its cultivation license in the third quarter of last year. A sales license is expected any day.

• The AB facility has a capacity for 1,000 kilograms, with active expansion plans underway.

• Invictus just closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.

• In Alberta, Invictus owns 100% of Acreage Pharms, which has a license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot phase 2 expansion plan with capital to expand an additional 75,000 square feet..

So, what we’re looking at here is a wildly undervalued company that has an amazing set of assets and a pipeline to produce which is poised to explode onto a recreational market that is already bursting at the seams.

They Actually Pay Dividends. Need We Say More?

No one expects pot producers to pay dividends—yet. It’s still early days, even with medical marijuana. Even so, Invictus has already rewarded its shareholders, to everyone’s surprise. It was a Christmas bonus no one expected, and its speaks volumes about this company and its management.

In the words of Invictus Chairman and CEO, Dan Kriznic, “It made sense to give back to those who supported us.”

Kriznic has been rated one of Business in Vancouver’s ‘Top 40 under 40’, and he’s put Invictus on the fast track to the market.

This CEO has turned $10-million companies into $150-million annual revenue generators. They’ve got a license to grow in more ways than one, and while they might not be a ‘green giant’ just yet, their undervaluation suggests they could be.

Why Invictus?

This company’s not only rewarding shareholders early, but it’s not afraid of hard work, and it has prime real estate for a cash crop that’s going to keep growing.

• The company has a funded production capacity of about 18,000 kilograms. Compared to its peers, this suggests significant undervaluation.

• And not only are its strains pre-approved by the health authorities, but they will reach into every corner of the market. It’s a marijuana octopus that has left no stone unturned.

• Invictus MD’s market cap to funded capacity is about 5 times the industry standard.

This is the only door to walk through to the land of marijuana profits, but it won’t be open much longer.

You can find out more on Invictus MD at the following links (TSX:IMH.V; OTC:IVITF)

Other companies worth watching:

Constellation Brands, Inc. (NYSE: STZ) is another solid pick in the realm of “sin stocks.” The company represents some of the most identifiable beers on the planet. Constellation Brands, Inc. operates in 5 countries and its products are sold in countless others. Established in 1945, this Fortune 500 company with a market cap of over $37B is a more than a safe bet.

Ball Corporation (NYSE:BLL) is another company that really knows how to take advantage of a booming industry. As a producer of metal packaging for food, personal care, and most notably, beverage industries, Ball Corporation is taking advantage of the craft beer boom in a way others may have neglected. Perhaps even more interesting; Ball Corporation is also involved in a number of other industries, including data exploitation solutions, cyber security, and spacecraft instruments. An ambitious stock to follow, that is for sure.

Ag Growth International Inc (TSE:AFN): The agricultural industry is sure to take advantage of the legal cannabis boom in Canada, and AG Growth International is as good a place as any to find value. With a nice dividend and a strong first half of 2017.

CanniMed Therapeutics Inc (TSE:CMED): This Canada-based plant biopharmaceutical company was the first licensed marijuana producer to sign a deal with a national pharmacy chain. With its stock trading at nearly a 52-week low, there is certainly value to be found in this company when the new Marijuana legislation kicks in.

Theratechnologies Inc (TSE:TH): Possibly the best performing pharmaceutical stock of 2017, Theratechnologies has seen its stock soar nearly 300 percent since January 1st. It will remain a stock to watch in drug markets, and if its current growth trend continues investors will be seeing some incredible returns.

By Charles Kennedy



PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buy or sell securities. Oilprice.com, Advanced Media Solutions Ltd, it’s owners, managers, employees, and assigns (collectively “The Company”) has been paid by a third party to disseminate this communication. This compensation is a major conflict with our ability to be unbiased, more specifically:

This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in our newsletter and on our website may be based on end-of- day or intraday data. If we own any shares we will list the information relevant to the stock and number of shares here. We have been compensated by Invictus MD Strategies Corp. to conduct investor relations advertising and marketing for [TSX:IMH.V; OTC:IVITF]. Oilprice.com receives financial compensation to promote public companies. This compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the company. The third party, profiled company, or their affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non- compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts experience a large increase in volume and share price during the course of investor relations marketing, which often end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, The Company often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications.

DISCLOSURE. The Company does not make any guarantee or warranty about what is advertised above. The Company is not affiliated with, any specific security. While the Company will not engage in front-running or trading against its own recommendations, The Company and its managers and employees reserve the right to hold possession in certain securities featured in its communications. Such positions will be disclosed AND will not purchase or sell the security for at least two (2) market days after publication.

NOT AN INVESTMENT ADVISOR. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

FORWARD-LOOKING STATEMENT. As defined in the United States Securities Act of 1933 Section 27(a), as amended in the Securities Exchange Act of 1934 Section 21(e), statements in this communication which are not purely historical are forward-looking statements and include statements regarding beliefs, plans, intent, predictions or other statements of future tense.

PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results


All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results.

AFFILIATES. Some or all of the content provided in this communication may be provided by an affiliate of The Company. Content provided by an affiliate may not be reviewed by the editorial staff member. Our affiliates may have their own disclosure policies that may differ from The Company’s policy.

TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://oilprice.com/terms-and-conditions If you do not agree to the Terms of Use http://oilprice.com/terms-and-conditions, please contact Oilprice.com to discontinue receiving future communications.

The information contained herein may change without notice.

Back to homepage

Leave a comment

Leave a comment

Oilprice - The No. 1 Source for Oil & Energy News